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Abstract
Glycosylation is one of the most common post-translational modifications in pro-
teins, existing in about 50% of mammalian proteins. Several research groups have
demonstrated that mass spectrometry is an efficient technique for glycopeptide identi-
fication. However, this problem is still challenging because of the enormous diversity
of glycan structures and the microheterogeneity of glycans. In addition, a glycopeptide
may contain multiple glycosylation sites, making the problem complex. Current soft-
ware tools often fail to identify glycopeptides with multiple glycosylation sites, hence
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we present GlycoMID, a graph-based spectral alignment algorithm that can identify
glycopeptides with multiple hydroxylysine O-glycosylation sites by tandem mass spec-
tra. GlycoMID was tested on mass spectrometry data sets of the bovine collagen α-(II)
chain protein, and experimental results showed that it identified more glycopeptide-
spectrum-matches than other existing tools, including many glycopeptides with two
glycosylation sites.
Introduction
Glycosylation, existing in about 50% mammalian proteins,1 plays vital roles in many cellular
events, such as signal transduction and receptor activation, and is related to many diseases,
including the congenital disorders of glycosylation and cancer.2,3 There has been increasing
demand for techniques and bioinformatics tools for the identification and characterization of
glycoproteins.
Glycans, which are attached to proteins (or lipids) in glycosylation, have many different
compositions and structures, making the patterns of glycosylation extremely diverse.2 Even
for one specific glycosylation site, there are many glycans that can be attached to the site,
which is called microheterogeneity.4 As a result, it is a challenging problem to identify and
characterize glycoproteins.
Mass spectrometry (MS) has been widely used for the identification of protein glyco-
sylation because it is high throughput and capable of sequencing glycopeptides as well as
decoding glycan structures.5–7 In bottom-up MS-based glycosylation analysis, glycoproteins
are first digested into short glycopeptides by a protease, and then the resulting glycopep-
tides are enriched and analyzed by liquid chromatography-tandem mass spectrometry (LC-
MS/MS).8,9 Fragmentation methods in MS/MS determine the patterns of fragment ions
observed in MS/MS spectra of glycopeptides. Collision-induced dissociation (CID) MS/MS
spectra contain many glycosidic ions, which involve the breakage of glycan bonds; electron
transfer dissociation (ETD) MS/MS spectra contain many ions with peptide backbone frag-
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mentation and intact glycosylation structures on the glycosylation sites; higher-energy colli-
sional dissociation (HCD) MS/MS undergoes a similar process as CID, but results in a ladder
of mono-, di-, or tri-saccharide oxonium ions and a dominated Y1 ion (peptide+GlcNAc) in
spectra.10–12
The two main types of glycosylation are N-linked and O-linked glycosylation; other types
of glycosylation include C-mannosylation, phosphoglycosylation, and glypiation.13 N-linked
glycosylation involves the attachment of glycans to asparagine or arginine residues, and O-
linked glycosylation to serine, threonine, tyrosine, hydroxyproline, or hydroxylysine (HyK)
residues.14 Moreover, N-glycans share a common core, GlcNAc2Man3, and follow biosyn-
thetic pathways in extension;15 O-glycan attachments have various types, such as glucose
(Glc), galactose (Gal), mannose, and fucose.13
Several studies have demonstrated that glycan structures can be successfully identified by
LC-MS/MS.16 There are three interconnected problems in analyzing a glycopeptide: deter-
mining the glycan structures, sequencing the peptide, and localizing the glycosylation sites.
Many software tools have been developed for the first problem, including SimGlycan,17 Gly-
coWorkbench,18 OSCAR,19 GLYCH,20 GlycosidIQ21 and STAT.22 Most of the tools were
designed for the determination of the structures of N-glycans by using CID/HCD MS/MS
spectra, which contain glycan fragment ions. There are also many software tools for the
second and third problems, such as GlycoPep Grader23 and GlycoPep Detector,24 which
utilize ETD MS/MS spectra that contain many peptide fragment ions. In addition, some
software tools provide a solution to the three interconnected problems, including Peptoon-
ist,25 GlycoFragwork,26 GlycoMaster DB,27 Sweet-Heart,28 MAGIC,29 and the one proposed
by Cheng et al.30 In these tools, the first problem is solved by a de novo or glycan database
search method, and the second and third problems by a peptide database search method.
However, the tools can analyze glycopeptides with only one glycosylation site due to the
complexity of glycan structures.
In this study, we focus on a special O-linked glycosylation in which Gal or glucose-
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galactose (Glc-Gal) moieties are attached to hydroxylysine residues in collagen. Although
multiple glycosylation sites may exist in a single peptide,31,32 most existing software tools fail
to identify this type of glycopeptides. To solve this problem, we propose GlycoMID, a spec-
tral alignment algorithm for the identification of glycopeptides with multiple hydroxylysine
O-glycosylation sites using MS/MS. In glycopeptide analysis, the determination of glycan
structures and the other two tasks: peptide sequencing and glycosylation site localization,
can be performed either separately or simultaneously. The tasks are performed separately
in MAGIC29 and simultaneously in GlycoMaster DB,27 BiOnic,33 and other peptide iden-
tification tools in which glycosylations are treated as variable PTMs. In GlycoMID, the
three tasks are also performed simultaneously: an MS/MS spectrum is searched against all
possible glycoforms of the peptides in a database to find a glycoform that best explains the
spectrum. A limitation of GlycoMID is that it identifies glycopeptides that involve only one
type of monosaccharides or several types of monosaccharides with the same mass, such as
Glc and Gal. GlycoMID was tested on MS/MS data sets of the collagen α-1(II) chain protein
from bovine cartilage, and experimental results showed that it identified more glycopeptides
than Mascot34 and X!Tandem.35
Methods
Mass spectrometry experiments
The protein collagen α-1 (II) (CO2A1) chain was acquired from bovine cartilage.36,37 Pepsinized
immunization-grade bovine CO2A1 samples were prepared in either an ammonium bicarbon-
ate buffer (ABC) or phosphate-buffered saline (PBS). The samples prepared in PBS were
digested by GluC; the samples prepared in ABC were digested by either trypsin or GluC.
The digested peptides were subjected to LC-MS/MS analysis using a nano-LC system
interfaced to an LTQ Orbitrap VelosTM mass spectrometer with a nano-ESI source. Two
configurations of the mass spectrometer were used to acquire MS/MS data. For the first
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configuration, each full MS scan (resolution 15 000) was followed by CID and HCD MS/MS
pair scans analyzing the 8 most intense ions in the MS scan, and the isolation width for
collecting parent ions was set as 3 m/z. The first configuration was applied to analyze one
sample prepared in PBS and digested by GluC as well as two samples prepared in ABC: one
digested by trypsin and the other by GluC. For the second configuration, each MS scan was
followed by triplicate scans of CID, HCD, and ETD analysing the 5 highest peaks in the
MS scan, and the isolation width for collecting parent ions was set as 4 m/z. The second
configuration was applied to analyze two samples prepared in ABC: one digested by trypsin
and the other by GluC. For both the configurations, CID and ETD spectra were collected in
low resolution in the linear ion trap, and HCD spectra were collected in high resolution in
the Orbitrap analyzer.38 A total of five MS/MS data sets were collected, containing 12 908
CID, 13 986 HCD, and 1 937 ETD MS/MS spectra.7
Collagen glycopeptide characterization problem
Unlike common glycosylation sites, O-linked glycosylation on collagen often involves only one
or two monosaccharides (Gal or Glc-Gal). In addition, a peptide of collagen may contain
multiple glycosylation sites. Because the glycans are short, an MS/MS spectrum of a collagen
glycopeptide often contains both common fragment ions, such as b- and y-ions in CID/HCD
spectra or c- and z•-ions in ETD spectra, and ions generated from a peptide bond cleavage
and a glycosidic bond cleavage (Fig. 1).16,31,39 These ions provide enough information for
simultaneous identification of glycosylation sites and glycan structures.
When an MS/MS spectrum is given and the unmodified form of the target peptide is
known, the objective of glycosylation analysis is to find a glycoform (glycopeptide) of the
peptide that best explains the spectrum. Because of the microheterogeneity of glycopeptides,
there are many candidate glycoforms of the peptide whose molecular masses match the
precursor mass of the spectrum. Since the number of candidate glycopeptides may be large,
how to efficiently find the best glycoform is a challenging problem.
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In the proposed algorithm, a peak counting score is used to evaluate glycopeptide-
spectrum-matches. The peak counting score between an experimental spectrum and a gly-
copeptide is the number of matched peak pairs (within an error tolerance) between the
spectrum and the theoretical spectrum of the glycopeptide. We formulate the glycopeptide
characterization problem on collagen as follows.
Collagen glycopeptide characterization problem Given an MS/MS spectrum, an un-
modified peptide, and a number m, find a glycoform of the peptide with m monosaccharides
that maximizes the peak counting score between the spectrum and the glycopeptide.
Representing the problem as a graph We will solve the glycopeptide characterization
problem using a graph-based method. While both charge 1 and charge 2 ions were used
for glycopeptide identification in the experiments, below only charge 1 ions are included to
simplify the description of the proposed algorithm. In general, an MS/MS spectrum of a col-
lagen glycopeptide is more complex than that of the unmodified form of the peptide because
glycosidic bonds in glycans may be cleaved, increasing the complexity of the spectrum. For
example, while the unmodified peptide AGFKEGQKGE has only one form of b6 ions with
charge 1, a glycoform of the peptide with m monosaccharides in a linear structure may have
m + 1 forms of b6 ions with charge 1 because the fragment ion may contain 0, 1, . . . , or m
monosaccharides (Fig. 1). We use only the number of monosaccharides, not the structure,
to distinguish fragment ions, that is, two fragment ions with the same charge state, amino
acids, and number of monosaccharides, but different glycan structures, are treated as the
same.
The proposed method can be applied to CID, HCD and ETD MS/MS spectra. Here
HCD MS/MS spectra are used to explain the method. To simplify the analysis, only b-
and y-ions are included in the generation of theoretical spectra of glycopeptides. We further
assume that monosaccharides in glycans have the same mass.
Let P = a1a2 . . . an be the unmodified form of a peptide and S an MS/MS spectrum of
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a glycoform of P with m monosaccharides. Let bi,j and yi,j be the m/z values of the singly
charged bi and yi ions with j monosaccharides of the glycoform, respectively. We generate
two (n− 1)× (m+1) matching matrices B and Y by mapping bi,j and yi,j, for 1 ≤ i ≤ n− 1
and 0 ≤ j ≤ m, to the spectrum S (Fig. 2(b)). If bi,j (yi,j) matches the m/z value of a peak
in S, then B[i, j] = 1 (Y [i, j] = 1); otherwise, B[i, j] = 0 (Y [i, j] = 0).
A directed graph containing n+1 layers is generated based on the matching matrices with
three steps (Fig. 2(c)). First, we generate n− 1 layers, each containing m+ 1 nodes, in the
middle of the graph. The jth node in the ith layer represents the prefix a1a2 . . . ai of P with
j monosaccharides, denoted by vi,j. When the prefix contains j monosaccharides, the suffix
ai+1 . . . an contains m− j monosaccharides. The peaks matching bi,j and yn−i,m−j are called
the matching peaks of the node vi,j. In addition, the glycan bonds in the prefix or suffix may
also be fragmented, resulting in peaks matching bi,0, . . . , bi,j−1, yn−i,0, . . . , yn−i,m−j−1. These
peaks are called the supporting peaks of the node. We designed two functions for assigning
a weight to a node in the n − 1 layers: the matching weight function and the combined
weight function. The first involves only matching peaks: the weight for the node vi,j is
wi,j = B[i, j] + Y [n − i,m − j]; the second considers both matching and supporting peaks:
the weight wi,j = B[i, j]+Y [n− i,m− j]+α(
∑j−1
j′=0B[i, j
′]+
∑m−j−1
j′=0 Y [n− i, j′]), where α is
a user-specified parameter for supporting peaks. Second, we add layer 0 and layer n. Layer 0
contains only one node v0,0, and layer n contains only one node vn,m. The weights of the two
nodes are 0. Third, directed edges are added between two nodes in neighboring layers. If a
glycan can be attached to the ith residue in the peptide, node vi−1,j′ is connected to node vi,j
by a directed edge if and only if j − β ≤ j′ ≤ j, where β is the number of monosaccharides
in the largest glycan in a collagen peptide. Otherwise, node vi−1,j′ is connected to vi,j by a
directed edge if and only if j′ = j.
Each path from v0,0 to vn,m corresponds to a glycoform of the peptide. For example, the
heaviest path in Fig. 2(c) corresponds to the glycopeptide AGFk(Gal)EGQk(Glc-Gal)GE
that best explains the peaks in the spectrum (Fig. 3(a)). Compared with the best glycopep-
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tide, another candidate glycopeptide AGFk(Glc-Gal)EGQk(Gal)GE corresponds to a path
with less weight (Fig. 2(c)) and explains less peaks in the spectrum (Fig. 3(b)). When the
theoretical spectrum of the glycoform contains only common b and y-ions with charge 1, the
matching weight of the path equals the peak counting score between the glycoform and the
spectrum. When the theoretical spectrum contains both common b and y-ions with charge
1 and those with glycosidic bond cleavages, the combined weight (α = 1) equals the peak
counting score. As a result, the glycopeptide characterization problem is reduced to the
heaviest path problem in the graph, which can efficiently solved by a dynamic programming
algorithm. The number of operations of the algorithm is proportional to nm2, where n is
the length of the peptide and m is the number of monosaccharides in the glycoform.
Database search In peptide identification, peptides are filtered by the precursor mass of
the spectrum to speed up database search. Similarly, we use the precursor mass of the
spectrum to filter peptides in glycopeptide identification. If the difference between the
precursor mass of the spectrum and the molecular mass of a peptide matches the mass
of a combination of allowed glycans (within an error tolerance), the peptide is chosen as a
candidate. Each candidate peptide is aligned with the spectrum to find the best glycoform
for it, and finally the best scoring glycoform among all candidate peptides is reported.
Results
We implemented GlycoMID in C++ and tested it on a desktop with an Intel Core i5 2.3 GHz
dual-core CPU and 8 GB memory.
Glycopeptide identification
Proteome Discoverer version 1.4 (Thermo Scientific, San Jose, CA) was used to convert
Thermo raw files to MGF files. Following the preprocessing steps in Ref. 7, noise peaks were
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removed using a signal-to-noise ratio 1.5, and MS/MS spectra without peaks were removed.
After preprocessing, 12 908 CID, 13 186 HCD and 1 937 ETD MS/MS spectra were kept. In
addition, the m/z values of the peaks were calibrated based on the differences between their
experimental and theoretical m/z values. (See the supplementary material for details.)
In database searches, three types of post-translational modifications (PTMs) were set as
variable PTMs: carbamidomethyl on cysteine, hydroxylysine, and hydroxyproline.40–42 The
error tolerance for precursor masses was set as 0.02 Da. Since the CID and ETD spectra were
collected in the linear ion trap of the mass spectrometer, the error tolerance for CID and
ETD fragment masses was set as 0.5 Da. The error tolerance for HCD fragment masses was
also set as 0.5 Da so that the same parameter setting was used for the three types of spectra.
The protein database contained the peptides of CO2A1 protein and shuﬄed decoy peptides
of the same size. Two approaches were used to estimate false discovery rates (FDRs) of
identified peptide-spectrum-matches. In the first approach, peptide-spectrum-matches with
or without glycosylation sites are combined to estimate FDRs. Using this approach Glyco-
MID identified 4 081 spectra, including 1 901 CID, 1 809 HCD, and 371 ETD spectra, from
28 031 spectra with a 1% spectrum-level FDR. A total of 2 873 unmodified peptide-spectrum-
matches and 1 208 glycopeptide-spectrum-matches were identified, including 1 152 matches
with one glycosylation site and 56 matches with two glycosylation sites. Of the matches with
one glycosylation site, 605 contain one Gal and 547 contain one Glc-Gal. Of the matches
with two glycosylation sites, 27 contain two Gals or two Glc-Gals, and 29 contain one Gal
and one Glc-Gal. A total of 125 glycopeptides were identified, and the numbers of identi-
fied glycopeptides using HCD, CID, and ETD spectrum were 98, 84, and 70, respectively
(Fig. 4(a)). In the second approach, we divided the identified peptide-spectrum-matches into
three groups with 0, 1, or 2 glycosylation sites, and estimated FDRs of identified peptide-
spectrum-matches in the three groups separately. Using the second approach, GlycoMID
identified 4 069 peptide-spectrum-matches (CID: 1 899, HCD: 1 825, and ETD: 345), includ-
ing 2 872 matches without glycosylation, 1 122 matches with 1 glycosylation site, and 75
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matches with 2 glycosylation sites, with a 1% spectrum-level FDR.
Coverage of the CO2A1 protein
The CO2A1 protein contains 68 lysine residues, of which 24 residues were identified as gly-
cosylation sites by GlycoMID. By manual investigation, the residue K634 was removed from
the list due to the low quality match, and the residue K781 was removed due to the ambiguity
of the glycosylation site localization. Of the remaining 22 residues, the residue K929 was gly-
cosylated with Glc-Gal only, and the other 21 were glycosylated with either Gal or Glc-Gal.
(See the supplementary material.) All the 22 residues are at the hydroxylysine positions of
the Gly-Xaa-HyK motif,36,37,43 and the glycosylation forms of the sites are consistent with
a previous study.7 The CO2A1 protein possesses 24 possible glycosylation sites with the
Gly-Xaa-Hyk motif, including the 22 identified glycosylation sites. Of the remaining two
sites, the site K773 was covered by identified peptides without glycosylation sites, and the
site K1130 was not covered by any identified peptides. The MS/MS spectra of the peptides
covering the site K1130 may lack enough fragment ion peaks, making them unidentifiable.
Because there are various glycosylated forms of the CO2A1 protein, the identified pep-
tides may have different PTMs (including different glycans) on a glycosylation site. Two
approaches were utilized to estimate the frequency that the CO2A1 protein has a PTM on a
glycosylation site. The first approach is based on spectral counting. Let n1, n2, n3, n4 be the
numbers of identified spectra that support the unmodified lysine residue, the hydroxylysine
residue, the hydroxylysine residue with a Gal, and the hydroxylysine residue with a Glc-Gal
on a glycosylation site, respectively. The frequency of the unmodified lysine residue on the
site is calculated as n1
n1+n2+n3+n4
, and those of other forms of modified residues are computed
similarly. In the second approach, the intensity of the precursor ion of an MS/MS spectrum
is treated as its weight, and the sums of the weights of the spectra that support the four
forms of lysine residues are computed for the estimation.
The frequencies of the four forms of the residues on the 22 identified glycosylation sites
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and the site K773 are summarized in Table 1. (See the supplementary material for details of
the identified peptides.) K470 and K956 were mainly unmodified or hydroxylated; K287 was
only hydroxylated or glycosylated; K299, K308, K374 and K803 were mainly hydroxylated
or glycosylated; K731 was mainly glycosylated; K929 was only glycosylated with Glc-Gal.
After manual investigation, we found that most peptides covering K929 contain an oxidized
methionine residue. Since this PTM was not included in the analysis, we only identified one
form of the residue (the hydroxylysine residue with a Glc-Gal) on the site K929.
Comparison of the weight functions
We described two functions in Section “Methods” for assigning weights to nodes in the
graph generated from the collagen glycopeptide characterization problem: the matching
weight function and the combined weight function. We tested the two functions on all of
the five data sets. Using a gradient method, we found that the combined weight function
achieved the best performance when α = 0.65. With a 1% spectrum-level FDR, the combined
weight function approach (α = 0.65) identified 4 081 peptide-spectrum-matches, including
1 208 matches with glycosylation sites (CID: 545, HCD: 524, and ETD: 139); the matching
weight function approach identified 3 980 peptide-spectrum-matches, including 1 129 matches
with glycosylation sites (CID: 489, HCD: 494, and ETD: 136). The reason for the better
performance of the combined weight function is that the fragmentation process sometimes
breaks both peptide and glycan bonds, resulting in both matching and supporting peaks.
Excluding supporting peaks in the matching weight function will deteriorate its performance.
Fragment ions
Because Gal and Glc-Gal are short glycans, it is common to observe fragment ions with a loss
of Gal or Glc-Gal. A fragment ion with only one Gal glycosylation site either keeps or loses
the Gal. These two forms are called a Gal-ion and a Gal-loss ion, respectively. We computed
the frequencies that Gal and Gal-loss ions were observed for b and y-ions with charge 1 or 2
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in CID and HCD spectra and for c and z• ions with charge 1 or 2 in ETD spectra, based on
the 605 identified peptide-spectrum-matches with one Gal glycosylation site from 271 CID,
275 HCD, and 59 ETD spectra. (See Section “Glycopeptide identification.”)
Below Gal b-ions with charge 1 in CID spectra are used to show how to compute the fre-
quency. We generate all theoretical Gal b-ions with charge 1 from the identified glycopeptide-
spectrum-matches from CID spectra, and find the theoretical ions that are matched to an
experimental peak in the corresponding spectrum. The frequency is computed as the ratio
between the number of the matched theoretical ions and the total number of the theoretical
ions.
Fig. 5 shows the frequencies of Gal and Gal-loss ions in CID, HCD, and ETD spectra.
While the ratio between the frequencies of Gal and Gal-loss ions in ETD spectra is about 7,
those in CID and HCD spectra are about 1, supporting previous studies.10–12
Similarly, using spectrum-peptide matches with one Glc-Gal glycosylation site, the fre-
quencies of fragment ions with a loss of Glc or Glc-Gal were obtained (Fig. 6). Compared
with ETD spectra, HCD and CID spectra contain more fragment ions with a loss of Gal or
Glc-Gal, which is consistent with previous findings:44–49 CID tends to produce fragments of
glycopeptides with minimal backbone fragmentation, and ETD tends to break glycopeptides
along the peptide backbones, preserving glycans.
Due to the presence of prevalent glycan loss peaks in CID/HCD MS/MS spectra, Gly-
coMID might report glycopeptides with incorrect glycan compositions and glycosylation
sites. To evaluate the performance of GlycoMID on the localization of glycosylation sites for
CID/HCD MS/MS spectra with glycan loss peaks, we compared CID/ETD and HCD/ETD
spectral pairs in the two data sets using HCD/CID/ETD alternate fragmentation. We ana-
lyzed the 36 CID/ETD and 41 HCD/ETD spectral pairs satisfying the condition that both
the spectra were mapped to glycoforms of the same peptide that contains multiple lysine
residues (candidate glycosylation sites), which may result in errors in the localization of
glycosylation sites. Of these spectral pairs, 9 CID/ETD and 12 HCD/ETD spectral pairs
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reported different localization results. Manual inspection showed that most localization re-
sults reported by the 9 CID and 12 HCD spectra were not reliable because of the absence of
key fragment ions with intact modifications.
Combination of CID, HCD and ETD MS/MS spectra
In the MS experiments, two data sets were generated using HCD/CID/ETD alternate frag-
mentation. The CID, HCD, and ETD spectra in these data sets were combined to improve
glycopeptide identification. Using the combined spectra and the parameter settings described
in Section “Glycopeptide identification,” we identified 1 470 peptide-spectrum-matches, in-
cluding 543 matches with glycosylation and 927 matches without glycosylation. Of the 1 470
matches, 171 matches with glycosylation and 163 matches without glycosylation were missed
by peptide identification using single spectra (Fig. 7). However, the combined approach also
missed 111 peptide-spectrum-matches identified by single spectra. By manual inspection, we
found that most of the 111 unidentified spectral triplets have only one high quality spectrum
in the triplet.
Comparison with Mascot and X!Tandem
We compared GlycoMID and Mascot on the CO2A1 data sets. The input of Mascot was
the same MGF files generated for GlycoMID. For Mascot, the error tolerances for precur-
sor and fragment masses were set as 0.02 Da and 0.5 Da, respectively. Fixed and variable
PTMs as well as the fragment ions for scoring were set as the same to the analysis in Section
“Glycopeptide identification.” All the MS/MS spectra were searched against the target-
decoy concatenated peptide database used in Section “Glycopeptide identification.” With
a 1% spectrum level FDR, Mascot identified 3 531 spectra, of which 845 were matched to
glycopeptides, A total of 91 glycopeptides were identified by Mascot, including 69, 63 and
38 glycopeptides from HCD, CID, and ETD MS/MS spectra, respectively (Fig. 4(b)). All
the glycopeptides identified by Mascot were also identified by GlycoMID, and GlycoMID
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identified more peptide-spectrum-matches than Mascot (Fig. 8). While GlycoMID includes
various fragment ions with and without glycan loss into the combined weight function, Mas-
cot does not use all the fragment ions in the computation of similarity scores. That might
be the main reason for the better performance of GlycoMID.
Although the scoring function of GlycoMID includes supporting peaks, it does not utilize
the information of peak intensities. After manually inspection, we found out that CID and
HCD MS/MS spectra contain more low-intensity noise peaks than ETD MS/MS spectra
in the test data sets. These noise peaks were treated the same as high intensity signal
peaks in the scoring function of GlycoMID. As a result, GlycoMID reported more decoy
random glycopeptide-spectrum-matches for CID/HCD spectra than ETD ones. Because
of these decoy matches, more CID/HCD target identifications of GlycoMID were filtered
out than ETD target identifications with the same FDR. This might be the reason that
the improvement of GlycoMID for CID/HCD spectra is less significant than that for ETD
spectra. To further improve the performance of GlycoMID, a better scoring function should
be designed to include both supporting peaks and patterns of the intensities of various
fragment ion peaks. In addition, the performance of GlycoMID can be improved by using
high accuracy and high resolution MS/MS spectra with small errors in the m/z values of
fragment ion peaks.
The data sets were also analyzed using X!Tandem, which reported less identifications than
Mascot and GlycoMID. The data sets contain peptides with hydroxylation of lysine and two
types of glycosylation of hydroxylysine residues, X!Tandem cannot handle three types of
variable PTMs on the same amino acid residue, resulting in the miss of many identifications.
Discussion and conclusions
We proposed an algorithm GlycoMID for the identification of glycopeptides with O-linked
glycosylation sites. The experiments on the CO2A1 data sets demonstrated that GlycoMID
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efficiently identified glycopeptides in the protein. Based the identified peptide-spectrum-
matches, a total of 22 lysine residue of CO2A1 were hydroxylated and glycosylated with
Glc-Gal or Gal moieties, which is consistent with previous studies. We also showed that
combining CID, HCD, and ETD spectra improved on the number of identified peptide-
spectrum-matched compared with single spectra.
A main limitation of the implementation of GlycoMID is that it identified glycopeptides
with only one type of monosaccharides or several types of monosaccharides with the same
mass. A glycopeptide may contain two or more types of monosaccharides with different
masses. When a length n glycopeptide contains k monosaccharides with t different masses,
the number of possible bi ions of the peptide is an exponential function proportional to kt, and
the number of nodes in the graph representing the peptide and its possible glycosylation sites
is proportional to nkt, making the algorithm inefficient. To further speed up the algorithm,
one method is to reduce the search space by allowing only a list of commonly observed
glycans, each corresponding to a combination of monosaccharides. When the number of
allowed glycans is g and the number of glycosylation sites is s, the number of nodes in the
graph representing the peptide and its possible glycosylation sites is proportional ngs, which
is generally smaller than nkt. The number of operations of the algorithm is proportional to
ngs.
GlycoMID was designed for the identification of glycopeptides, not for the computation
of localization scores of glycosylation sites. For an MS/MS spectrum, it reports only a best
scoring glycopeptide with its glycosylation sites and structures, not localization scores of
the identified glycosylation sites. Many methods have been proposed for the localization
of PTMs, such as A-score,50 PTM score,51 PhosphoRS52 and Mascot Delta Score.53 These
methods compute a PTM localization score based on the similarity scores between an MS/MS
spectrum and a peptide with different PTM sites. Similarly, the proposed algorithm can be
modified to report the similarity scores between an MS/MS spectrum and a glycopeptide
with different glycosylation sites, which can be utilized to compute localization scores of
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glycosylation sites.
Because of the complexity of glycosylation and the similarity of glycoforms from the same
peptide, multiple glycoforms with the same molecular mass may not be separately by LC,
resulting in multiplexed MS/MS spectra of a mixture of the glycoforms. For such a spectrum,
GlycoMID reports a glycoform with the highest similarity score, not multiple glycoforms.
Computational methods have been proposed for the identification of multiple proteoforms
from a multiplexed spectrum in histone protein studies.54,55 These methods can be applied
to identify multiple glycoforms from a multiplexed MS/MS spectrum.
Supporting Information
The CO2A1 data sets are publicly available at MassIVE (http://massive.ucsd.edu/) with
accession id MSV000079174. The software GlycoMID is available at
http://proteomics.informatics.iupui.edu/software/glycomid/.
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Table
Table 1: The frequencies of the unmodified lysine residue, the hydroxylysine residue, the
hydroxylysine residue with a Gal, and the hydroxylysine residue with a Glc-Gal on the 22
identified glycosylation sites and the site K773 in the CO2A1 protein. Two frequencies
are reported for each form of the lysine residue at each glycosylation site. The first is
estimated by the spectral counting method, and the second by the method that incorporates
the intensities of precursor ions.
Relative frequency (%)Glycosylation
site Unmodified K HyK Gal-HyK Glc-Gal-HyK
K287 0.00/0.00 65.94/76.72 15.68/11.44 18.38/11.84
K299 2.79/0.83 54.98/46.73 27.09/36.25 15.14/16.19
K308 4.19/1.13 71.85/78.55 11.98/11.83 11.98/8.49
K374 0.32/0.25 29.62/19.37 40.44/45.90 29.62/34.48
K419 9.52/11.39 49.21/44.06 15.87/13.80 25.40/30.75
K452 22.64/55.65 24.53/27.29 22.64/9.53 30.19/7.53
K464 10.00/8.24 54.44/66.97 16.67/13.72 18.89/11.07
K470 50.00/35.20 33.55/50.22 9.87/10.47 6.58/4.11
K527 33.97/53.47 19.62/9.43 22.97/21.04 23.44/16.06
K542 34.38/26.47 0.00/0.00 28.12/27.28 37.50/46.25
K608 50.00/55.66 7.14/26.83 21.43/11.22 21.43/6.29
K620 46.18/31.55 37.82/31.66 7.27/6.68 8.73/30.14
K731 9.56/1.91 3.48/1.18 20.87/14.57 66.09/82.34
K764 36.54/27.83 25.00/44.19 17.31/12.35 21.15/15.63
K773 87.06/86.65 12.94/13.35 0.00/0.00 0.00/0.00
K803 6.32/9.83 46.84/40.24 19.47/10.20 27.37/39.73
K848 19.32/12.21 35.88/48.46 32.27/32.88 12.53/6.45
K857 15.00/12.97 70.00/71.44 7.50/9.59 7.50/6.00
K884 14.29/5.42 4.76/2.41 7.14/14.72 73.81/77.45
K929 0.00/0.00 0.00/0.00 0.00/0.00 100.00/100.00
K956 48.76/64.36 40.50/32.91 8.26/2.33 2.48/0.40
K1055 38.32/33.63 34.58/56.88 16.82/6.40 10.28/3.09
K1118 29.55/18.63 61.82/80.42 4.54/0.49 4.09/0.46
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Figure 1: Possible fragment ions generated from a glycopeptide AGFk(Glc-Gal)EGQKGE,
in which k is a hydroxylysine residue.
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Figure 2: Conversion from the glycopeptide characterization problem to the heaviest path
problem in a graph. (a) An HCD MS/MS spectrum annotated with possible fragment ions
of glycoforms of AGFkEGQkGE with 3 Gal/Glc monosaccharides, where k represents a
hydroxylysine residue. (b) The matching matrices B and Y generated from the annotated
spectrum. (c) A graph is generated based on the matrices B and Y using the combined
weight function (α = 0.5). The heaviest path, shown in bold, corresponds to the glyco-
form AGFk(Gal)EGQk(Glc-Gal)GE. The path from layer 0 to layer 10 containing the blue
subpath corresponds to the glycoform AGFk(Glc-Gal)EGQk(Gal)GE.
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Figure 3: Comparison between two glycopeptides matched to an MS/MS spectrum. (a)
The HCD MS/MS spectrum in Fig. 2(a) is annotated with fragment ions of glycopep-
tide AGFk(Gal)EGQk(Glc-Gal)GE, which corresponds to the heaviest path in Fig. 2(c).
(b) The same spectrum is annotated with fragment ions of glycopeptide AGFk(Glc-
Gal)EGQk(Gal)GE, which corresponds to the path with the blue subpath in Fig. 2(c) with
less weight. The peak in the shade area is annotated by AGFk(Gal)EGQk(Glc-Gal)GE, not
by AGFk(Glc-Gal)EGQk(Gal)GE.
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Figure 4: The numbers of glycopeptides identified with different fragmentation methods: (a)
GlycoMID; (b) Mascot.
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Figure 5: Frequencies of Gal and Gal-loss fragment ions in the identified 605 glycopeptide-
spectrum-matches with only one Gal glycosylation sites, including 271 CID, 275 HCD, and
59 ETD spectra. (a) Prefix fragment ions with charge 1 (b-ions for CID and HCD spectra
and c-ions for ETD spectra). (b) Suffix fragment ions with charge 1 (y-ions for CID and
HCD spectra and z•-ions for ETD spectra). (c) Prefix fragment ions with charge 2 (b-ions
for CID and HCD spectra and c-ions for ETD spectra). (d) Suffix fragment ions with charge
2 (y-ions for CID and HCD spectra and z•-ions for ETD spectra).
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Figure 6: Frequencies of various fragment ions in the identified 547 glycopeptide-spectrum-
matches with only one Glc-Gal glycosylation sites, including 251 CID, 228 HCD, and 68
ETD spectra. Three types of fragment ions that contain only one glycosylation site with
an Glc-Gal are compared: fragment ions keeping the Glc-Gal (Glc-Gal ions), losing the Glc
(Glc-loss ions), and losing the Glc-Gal (Glc-Gal-loss ions). (a) Prefix fragment ions with
charge 1 (b-ions for CID and HCD spectra and c-ions for ETD spectra). (b) Suffix fragment
ions with charge 1 (y-ions for CID and HCD spectra and z•-ions for ETD spectra. (c) Prefix
fragment ions with charge 2 (b-ions for CID and HCD spectra and c-ions for ETD spectra).
(d) Suffix fragment ions with charge 2 (y-ions for CID and HCD spectra and z•-ions for ETD
spectra).
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Figure 7: Comparison of the numbers of peptide-spectrum-matches identified by single spec-
tra and by combining multiple spectra on the data sets with CID/HCD/ETD triplets: (a-c)
glycopeptide-spectrum-matches; (d-f) peptide-spectrum-matches without glycosylation.
(a) (b) (c) (d) (e) (f)
Figure 8: Comparison between the numbers of peptide-spectrum-matches reported by Mas-
cot and GlycoMID with a 1% spectrum level FDR. (a-c) Glycopeptide-spectrum-matches
identified from CID, ETD, and HCD spectra, respectively. (d-f) Peptide-spectrum-matches
without glycosylation identified from CID, ETD, and HCD spectra, respectively.
29
